Objective-To gain information concerning the association between parvovirus B19 infection and arthritis.
both, from a total of 77 adult patients with various arthropathies (rheumatoid arthritis 13; mechanical arthropathies 11; crystal induced arthritis 13 ; idiopathic mono/oligoarthritis 25; suspicion of viral arthritis 15) were tested for the presence of the viral genome and anti-B19 antibodies. B19 DNA in blood and synovial fluid was investigated by nested polymerase chain reaction, and anti-B19 IgM and IgG antibodies were detected in blood by enzyme immunoassay. Results-A recent parvovirus infection was documented by the presence of anti-B19 IgM antibodies in the blood of 13 patients. B19 DNA, together with anti-B19 IgM and IgG antibodies, were detected in the blood of seven patients who had an acute transient arthritis, putatively of viral origin. Viral DNA was detected in a synovial fluid sample and in the blood of one patient with monoarthritis who had an anti-B19 IgG response only. Conclusions-The prevalence of anti-B19 IgG antibody in these patients with various forms of arthritis (63%) was within the same range as that in the general population (blood donors). How patients there was a clinical suspicion of viral arthritis (acute onset with fever, sore throat, myalgias, arthralgias, arthritis, and sometimes a rash). These cases occurred within one year, without any regional clustering.
DNA was obtained from serum by heating and from synovial fluid by treatment with proteinase K as previously described.9 After isolation of DNA, a nucleic acid fragment within the sequence coding for the major capsid protein (VP2) of parvovirus B19 was amplified by nested polymerase chain reaction (PCR).9 Briefly, the first amplification consisted of 35 cycles using the outer primers TJI (nucleotide 3775-3792, 5'-TTC7IFFIT-CAGClITTlAGG-3') and TJII (nucleotide 3956-3975, 3'-GTACTTCTGGTACGTTA-AGT-5') numbered according to Shade et al."0
The second round of amplification consisted of 35 cycles using the inner primers 968 (nucleotide 3818-3837, 5'-TATAAGTTTTC-CTCCAGTGCC-3') and 967b (nucleotide 3920-3938, 3'-TGTAATCCTCCACTGG-GT-5'). PCR products were analysed by agarose gel electrophoresis. A negative control for the DNA extraction was included in each PCR run. Each fourth sample was a negative control for the PCR reaction containing no DNA. The samples were coded and each sample analysed in duplicate.
Association between human parvovirus Bl 9 infection and arthritis Rheumatoid arthritis (with rheumatoid factors) 0 (0%) (n = 4) 0 (0%) (n = 4) 3 (75%) (n = 4) 1 (25%) (n = 4) 0 (0%) (n = 4) 0 (0%) (n = 12) Crystal induced arthritis 1 (14%) (n = 7) 0 (0%) (n = 7)
2 (29%) (n = 7) 4 (57%) (n = 7) 0 (0%) (n = 7) 0 (0%) (n = 12) Mechanical arthropathies 0 (00/a) (n = 7) 0 (0%) (n = 7) 4 (57%) (n = 7) 3 (43%) (n = 7) 0 (0%) (n = 7) 0 (0%) (n = 10) Idiopathic mono/oligoarthritis 2 (9-5%) (n = 21) 2 (9.5%) (n = 21) 9 (43%) (n = 21) 8 (38%) (n = 21) 1 (5%) (n = 21) 1 (6%) (n = 16) Viral arthritis 0 (0%) (n = 15) 8 (53%) (n = 15) 6 (40%) (n = 15) 1 (7%) (n = 15) 7 (47%) (n = 15) NA Total 3 (6%) (n = 54) 10 (19%) (n = 54) 24 (44%) (n = 54) 17 (31%) (n = 54) 8 (15%) (n = 54) 1 (2%) (n = 50) n = Number of patients tested; NA = no material available. 
